Changing landscape of psoriasis therapy

Article

Since the mid-1980s, mounting evidence has shown that psoriasis is an immune disorder - specifically, that abnormal T-cell activity is a critical component of the disease.

Related Videos
Related Content

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Journal Digest: September 20

September 20th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Journal Digest: September 20

September 20th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Journal Digest: September 20

September 20th 2023

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

September 20th 2023
© 2023 MJH Life Sciences

All rights reserved.